![]() |
市場調查報告書
商品編碼
2048432
實驗室用品市場-全球產業規模、佔有率、趨勢、機會和預測:按產品、地區和競爭對手分類,2021-2031年Laboratory Supplies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Equipment, Disposables), By Region & Competition, 2021-2031F |
||||||
全球實驗室耗材市場預計將從 2025 年的 421.2 億美元大幅成長至 2031 年的 631.8 億美元,複合年成長率為 6.99%。
該市場涵蓋了科學研究、臨床診斷和工業品管所需的各種耗材、試劑和設備。這一成長主要得益於製藥和生物技術產業研發投入的增加,這些產業需要穩定的高品質實驗室材料供應。同時,慢性病發病率的上升也推動了對診斷檢測的需求,而嚴格的產品安全監管要求也促使各行業採用可靠的分析程序。特別是,根據歐洲化學工業理事會(CEFIC)的預測,到2024年,歐盟27國化學工業的研發創新支出預計將達到104億歐元,這凸顯了支撐這些關鍵實驗室材料需求的巨額投資。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 421.2億美元 |
| 市場規模:2031年 | 631.8億美元 |
| 複合年成長率:2026-2031年 | 6.99% |
| 成長最快的細分市場 | 裝置 |
| 最大的市場 | 北美洲 |
儘管市場呈現成長態勢,但由於引進和維護先進分析儀器成本高昂,該市場仍面臨許多挑戰。這種財務負擔嚴重影響了小規模研究機構和學術設施的營運預算,可能阻礙其採用關鍵技術。此外,供應鏈波動常常加劇這些成本壓力,導致關鍵耗材的交付延遲和價格波動。這些經濟限制因素可能會阻礙高階實驗室解決方案的普及,並減緩市場整體擴張速度。
全球實驗室耗材市場的主要驅動力是製藥和生技產業研發投入的增加。隨著各公司加強研發新治療方法,尤其是在腫瘤學和免疫學等領域,對高品質試劑、層析管柱和塑膠耗材的需求激增。強生公司在2025年4月發布的投資人概況中揭露,其研發預算高達172億美元,便是這一趨勢的鮮明例證。這凸顯了推動這項需求的巨額資本支出。此類企業支出直接促進了關鍵設備供應商的收入穩定成長,這些供應商為藥物研發提供了必要的基礎設施。例如,根據Investing.com在2025年10月報道,賽默飛世爾科技公司季度銷售額成長至111.2億美元,主要得益於強勁的業務表現和對科學儀器的需求。
同時,政府對生命科學領域的資金和津貼大幅增加,大大促進了市場擴張,特別惠及學術和非營利研究機構。公共資金對於基礎科學研究至關重要,因為基礎科學研究高度依賴常用實驗室耗材和先進設備的穩定供應。根據美國國會網站(Congress.gov)2025年12月發布的報告《美國國立衛生研究院(NIH)撥款:1996-2026財政年度申請》,NIH在2025會計年度共獲得469.95億美元的專案資金。這筆巨額資金將使大學和聯邦實驗室能夠升級其設施並採購必要的耗材,從而穩定供應鏈需求,抵禦私人投資固有的波動性,並確保診斷和生物醫學領域的市場持續成長。
全球實驗室耗材市場面臨許多障礙,其中最主要的原因是先進分析儀器的初始投資和持續維護成本龐大。質譜儀和自動化定序平台等尖端設備需要大量的預付資金,這往往令小規模研究機構、獨立診斷檢查室和學術機構難以負擔。這種經濟壁壘限制了市場的整體規模,迫使預算緊張的機構推遲採購或延長老舊設備的使用時間,而不是投資最新、最高效的技術。因此,新儀器的普及速度放緩,直接降低了對相容耗材和試劑的需求,而這些耗材和試劑正是市場持續收入的重要組成部分。
此外,供應鏈的不確定性加劇了這些財務困境,關鍵零件的價格波動難以預測,進一步擠壓了營運預算。當大部分可用資金必須用於購買和維護硬體時,用於擴展實驗能力的資金就相應減少。根據歐洲製藥工業協會聯合會(EFPIA)的報告,歐洲以研發為基礎的製藥業在2024年研發投入約550億歐元。如此龐大的支出不僅展現了該產業的龐大規模,也凸顯了維持營運所需的龐大資金。因此,市場活動集中在資金雄厚的大型企業手中,為小型企業的發展帶來了競爭激烈且充滿挑戰的環境。
隨著各組織努力減少整個供應鏈的碳排放,籌資策略正因綠色實驗室認證項目和永續包裝的採用而發生根本性轉變。實驗室越來越優先考慮那些提供檢驗的低碳廢棄物和循環經濟解決方案的供應商,以減輕塑膠和化學廢棄物處理對環境的影響。這項策略轉變的基礎是產業日益嚴格遵守與企業氣候目標相符的各項環境標準。正如My Green Lab於2024年11月發布的《生物技術和製藥行業碳影響報告》中所述,在擁有可靠排放數據的公司中,31%的公司已正式設定了符合1.5 度C溫控目標的中期範圍1和範圍2目標,這表明企業正顯著轉向以合規為主導、經認證的永續產品採購。
同時,生物製程領域正迅速轉向一次性技術(SUT)。這一趨勢的驅動力源於製藥生產對更高柔軟性和更低交叉污染風險的需求。與傳統的不銹鋼系統相比,一次性技術無需耗時的清潔驗證,並可實現快速的設備切換,這對於複雜細胞和基因療法的生產至關重要。這種營運模式的轉變清晰地體現在專注於這些技術的供應商所創造的巨額收入上。 Zartorius 的生物製程解決方案部門主要為生物製藥生產提供一次性解決方案,其 2024 年年度報告(2025 年 2 月發布)顯示,該部門銷售額達 26.9 億歐元,凸顯了該行業對一次性製程基礎設施的持續依賴。
The Global Laboratory Supplies Market is projected to expand significantly, from USD 42.12 Billion in 2025 to USD 63.18 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 6.99%. This market encompasses a broad spectrum of consumables, reagents, and instruments essential for scientific research, clinical diagnostics, and industrial quality control. Growth is largely propelled by increased research and development (R&D) investments in the pharmaceutical and biotechnology industries, which demand a steady supply of high-quality experimental materials. Concurrently, the rising incidence of chronic diseases fuels diagnostic testing volumes, and stringent regulatory requirements for product safety mandate robust analytical procedures across various industries. Notably, in 2024, the EU27 chemical industry's research and innovation spending reached €10.4 billion, according to the European Chemical Industry Council, highlighting the substantial financial commitment that sustains the demand for these vital laboratory resources.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 42.12 Billion |
| Market Size 2031 | USD 63.18 Billion |
| CAGR 2026-2031 | 6.99% |
| Fastest Growing Segment | Equipment |
| Largest Market | North America |
Despite this growth, the market faces a substantial challenge due to the considerable acquisition and upkeep costs associated with sophisticated analytical equipment. This financial strain can critically impact the operational budgets of smaller research institutions and academic facilities, impeding their capacity to acquire essential technologies. Furthermore, fluctuations within the supply chain frequently intensify these cost pressures, leading to delays and unpredictable pricing for vital consumables. These economic limitations have the potential to impede the adoption of high-end laboratory solutions and temper the market's overall expansion pace.
Market Driver
The primary driving force behind the Global Laboratory Supplies Market is the increasing investment in research and development within the pharmaceutical and biotechnology industries. As companies intensify their efforts to innovate new therapeutics, especially in areas like oncology and immunology, the demand for premium reagents, chromatography columns, and plastic consumables has surged. A clear example of this trend is Johnson & Johnson's allocation of $17.2 billion towards R&D, as reported in their '2024 Investor Fact Sheet' in April 2025, demonstrating the significant capital expenditure propelling this demand. Such corporate spending directly contributes to consistent revenue growth for major equipment suppliers, who provide the essential infrastructure for drug discovery. For instance, Thermo Fisher Scientific reported a quarterly revenue increase to $11.12 billion, largely attributed to strong operational performance and demand for scientific instruments, as detailed by Investing.com in October 2025.
Concurrently, a substantial rise in government funding and grants for life sciences is significantly boosting market expansion, particularly benefiting academic and non-profit research institutions. Public financing is crucial for fundamental scientific research, which depends heavily on a consistent flow of both general laboratory supplies and advanced instrumentation. The National Institutes of Health (NIH) received a total program funding of $46.995 billion for fiscal year 2025, as stated in the Congress.gov report 'National Institutes of Health (NIH) Funding: FY1996-FY2026 Request' from December 2025. This substantial funding allows universities and federal laboratories to upgrade their facilities and acquire necessary consumables, thereby stabilizing supply chain demand against the inherent fluctuations of private sector investments and ensuring continuous market growth across diagnostic and biomedical sectors.
Market Challenge
The global laboratory supplies market faces a significant hurdle due to the substantial acquisition and ongoing maintenance costs of advanced analytical equipment. State-of-the-art instruments, including mass spectrometers and automated sequencing platforms, require considerable initial capital outlays that are often unaffordable for smaller research organizations, independent diagnostic laboratories, and academic facilities. This financial obstacle restricts the overall market size, compelling budget-limited entities to postpone purchases or prolong the use of outdated machinery instead of investing in modern, more efficient technologies. As a result, the adoption rate of new equipment slows, directly diminishing the subsequent demand for compatible consumables and reagents, which constitute a significant part of the market's recurring revenue.
Moreover, uncertainties within the supply chain aggravate these financial difficulties by causing unpredictable price shifts for essential components, further stretching operational budgets. When a large proportion of available funds must be allocated to acquiring and maintaining hardware, less capital is available for expanding experimental capabilities. The European Federation of Pharmaceutical Industries and Associations reported that in 2024, the research-based pharmaceutical industry in Europe invested approximately €55 billion in R&D. While this considerable expenditure illustrates the sector's vast scale, it also highlights the immense financial requirements for sustained operations, thereby centralizing market activity among major, well-funded companies and creating a difficult competitive and growth environment for smaller participants.
Market Trends
Procurement strategies are being fundamentally transformed by the adoption of Green Lab Certification programs and sustainable packaging, as institutions aim to reduce carbon emissions throughout their supply chains. Laboratories are increasingly favoring suppliers that provide validated low-carbon consumables and circular economy solutions, seeking to lessen the environmental footprint of plastic waste and chemical disposal. This strategic shift is underscored by the industry's growing adherence to strict environmental standards, aligning with corporate climate objectives. As noted by My Green Lab in its 'Carbon Impact of Biotech and Pharma Report' in November 2024, 31% of companies with robust emissions data have officially established medium-term Scope 1 and 2 targets consistent with the 1.5°C pathway, indicating a significant, compliance-driven move towards purchasing certified sustainable products.
Concurrently, the market is observing a rapid transition to single-use technologies (SUT) in bioprocessing, a trend driven by the demand for enhanced flexibility and reduced risks of cross-contamination in drug manufacturing. In contrast to conventional stainless-steel systems, SUTs eliminate the need for time-intensive cleaning validations and enable swift facility changeovers, which is crucial for the production of intricate cell and gene therapies. This operational evolution is clearly reflected in the substantial revenues generated by providers specializing in these technologies. Sartorius's Bioprocess Solutions Division, which predominantly offers single-use solutions for biopharmaceutical manufacturing, reported sales revenue of €2.69 billion in its 'Annual Report 2024' (February 2025), highlighting the industry's continued reliance on disposable processing infrastructure.
Report Scope
In this report, the Global Laboratory Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Laboratory Supplies Market.
Global Laboratory Supplies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: